Albert P Parker is Chief Legal Officer of Zynerba Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zynerba Pharmaceuticals, Inc.
11 Oct 23
4
Zynerba Pharmaceuticals, Inc.
17 Feb 23
4
Zynerba Pharmaceuticals, Inc.
9 Feb 23
4
Zynerba Pharmaceuticals, Inc.
2 Feb 23
4
Zynerba Pharmaceuticals, Inc.
25 Jan 23
4
Zynerba Pharmaceuticals, Inc.
15 Feb 22
3
Zynerba Pharmaceuticals, Inc.
15 Feb 22
4
OncoCyte Corp
15 Dec 20
4
OncoCyte Corp
5 Aug 20
4
Oncocyte Corp
12 Feb 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 278,333 | 0.00 | 0 | |
| 10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 85,000 | 0.00 | 278,333 |
| 10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 33,685 | 0.00 | 193,333 | |
| 10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.7 | 200,000 | 540.00 k | 0 |